UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
Avery Dennison
AVY
$13.3B
| $114M | 0.02% |
700,265
-137,022
| -16% | -$23.6M |
2013 Q2
49 quarters
|
|
452
IDEX
IEX
$17.3B
| $113M | 0.02% |
693,067
-157,068
| -18% | -$26.5M |
2013 Q2
49 quarters
|
|
453
Dollar Tree
DLTR
$23.2B
| $112M | 0.02% |
1,189,146
-240,491
| -17% | -$25.7M |
2013 Q2
49 quarters
|
|
454
Samsara
IOT
$23B
| $112M | 0.02% |
3,005,344
-986,137
| -25% | -$36.6M |
2022 Q2
13 quarters
|
|
455
Bio-Rad Laboratories Class A
BIO
$9.4B
| $111M | 0.02% |
397,171
+380,422
| +2,271% | +$104M |
2013 Q2
49 quarters
|
|
456
Gaming and Leisure Properties
GLPI
$11.4B
| $110M | 0.02% |
2,369,851
+2,077,937
| +712% | +$97.9M |
2013 Q4
47 quarters
|
|
457
Royalty Pharma
RPRX
$27.1B
| $110M | 0.02% |
3,129,936
-947,063
| -23% | -$34.3M |
2021 Q1
18 quarters
|
|
458
Masco
MAS
$14.3B
| $110M | 0.02% |
1,567,486
-387,418
| -20% | -$27.3M |
2013 Q2
49 quarters
|
|
459
Omnicom Group
OMC
$22B
| $110M | 0.02% |
1,348,150
-394,670
| -23% | -$29.8M |
2013 Q2
49 quarters
|
|
460
Snap-on
SNA
$19B
| $110M | 0.02% |
316,376
-58,532
| -16% | -$19.2M |
2013 Q2
49 quarters
|
|
461
Live Nation Entertainment
LYV
$39.5B
| $109M | 0.02% |
668,803
-188,518
| -22% | -$29.8M |
2013 Q2
49 quarters
|
|
462
Darden Restaurants
DRI
$24.4B
| $109M | 0.02% |
573,309
-196,111
| -25% | -$40.3M |
2013 Q2
49 quarters
|
|
463
Everest Group
EG
$14.9B
| $109M | 0.02% |
310,545
-43,143
| -12% | -$14.6M |
2013 Q2
49 quarters
|
|
464
Annaly Capital Management
NLY
$13.8B
| $109M | 0.02% |
5,374,696
+4,286,893
| +394% | +$88.9M |
2023 Q1
10 quarters
|
|
465
Neurocrine Biosciences
NBIX
$13.8B
| $107M | 0.02% |
765,237
-622,398
| -45% | -$84.3M |
2013 Q2
49 quarters
|
|
466
Rollins
ROL
$16.1B
| $107M | 0.02% |
1,828,583
-373,582
| -17% | -$21.2M |
2013 Q2
49 quarters
|
|
467
Allegion
ALLE
$13.2B
| $107M | 0.02% |
605,604
-123,691
| -17% | -$20.4M |
2013 Q4
47 quarters
|
|
468
Equity Lifestyle Properties
ELS
$11.8B
| $107M | 0.02% |
1,767,869
-438,636
| -20% | -$26.6M |
2013 Q2
49 quarters
|
|
469
Halliburton
HAL
$27.9B
| $107M | 0.02% |
4,354,714
-1,801,025
| -29% | -$39.8M |
2013 Q2
49 quarters
|
|
470
Voya Financial
VOYA
$8.49B
| $107M | 0.02% |
1,431,835
+553,675
| +63% | +$40.8M |
2013 Q3
48 quarters
|
|
471
Akamai
AKAM
$12.7B
| $107M | 0.02% |
1,409,734
-369,149
| -21% | -$28.5M |
2013 Q2
49 quarters
|
|
472
Texas Pacific Land
TPL
$23.9B
| $105M | 0.02% |
338,235
-474
| -0.1% | -$149K |
2021 Q2
17 quarters
|
|
473
CF Industries
CF
$18.3B
| $104M | 0.02% |
1,163,537
-240,700
| -17% | -$21.5M |
2013 Q2
49 quarters
|
|
474
Graco
GGG
$13.2B
| $104M | 0.02% |
1,226,490
-278,218
| -18% | -$23.8M |
2013 Q2
49 quarters
|
|
475
TransUnion
TRU
$14.2B
| $103M | 0.02% |
1,232,460
-435,931
| -26% | -$39.6M |
2015 Q4
39 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.